Lookup from volume / page
There is more than one article on this page. Which one would you like?
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
- Long term survival and clinical efficacy in patients with advanced pancreatic and small bowel metastatic neuroendocrine tumours (GEP-NET) after i.v. 90Y DOTATATE